RESTORIS 180726-1Recalls & reported problems
Mako Surgical Corp. · MCK Inlay Tibial Component · Class 2 · Implant
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00848486001155), received between Jan 15, 2024 and Jan 15, 2024 — classified as 1 injury.
The most frequently reported specific device problem is “Degraded” (1 report).
5 other recalls cover devices cleared under the same FDA submission (K082172, K090763); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Degraded1
- Unintended Movement1
Patient problems
- Arthritis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 15, 2024Degraded; Unintended Movement; Degraded; Unintended Movement
IT WAS REPORTED THROUGH STRYKER FACEBOOK PAGE: "MY MAKO KNEE LASTED 8 WEEKS ! I HAD A REVISION A FEW YEARS LATER!". 04-DEC-2023: UPDATE PER CONVERSATION WITH PATIENT: "PATIENT HAD A PRIMARY RIGHT MAKO PARTIAL KNEE AND WAS REVISED TO CONVERT TO A FULL KNEE. PATIENT REPORTED THAT SURGEON CHOSE TO CONVERT TO A FULL KNEE AS THE "OUTER PORTION OF THE HIS NATIVE KNEE BECAME BONE ON BONE". UPDATE: PER CLINICIAN REVIEW OF PROVIDED MEDICAL RECORDS: X-RAYS IN 2016 AND 2017 SHOWED ADVANCED OA OF THE LATERAL COMPARTMENT AND WEAR OF THE POLYETHYLENE WITH SOME LIKELY SUBSIDENCE.
Patient problems: Arthritis
MAUDE report 18510303 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K082172, K090763. One submission often covers many models, so check the product and lot details in each record.
- Z-1385-2023 · Mar 10, 2023 · Open, Classifiedstryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 5 RM/LL), REF 170615, intended for use in a Partial Knee Arthroplasty surgical procedure
- Z-1386-2023 · Mar 10, 2023 · Open, Classifiedstryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty surgical procedure
- Z-2051-2018 · Jan 19, 2018 · TerminatedRestoris MCK Onlay Insert Extractor.
- Z-1031-2016 · Jan 15, 2016 · TerminatedRestoris Multicompartmental Knee (MCK) System RESTORIS MCK is indicated for single or multi-compartmental knee replacement used in conjunction with RIO.
- Z-1132-2014 · Jan 9, 2014 · TerminatedRestoris Multicompartmental Knee (MCK) System is an implant system designed to be used with MAKO's Robotic Arm Interactive Orthopedic System (RIO). It is composed of a unicompartme
Other PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- Scorpio 73-3910Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls4 reports
- Scorpio 73-3508Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls3 reports
- Arthrex® AR-503-TTTCArthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall15 reports
- Arthrex® AR-503-TTTFArthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- Scorpio 73-3308Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall0 reports
- Arthrex® AR-504-PSC9Arthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER11 reports
- Arthrex® AR-504-PSD0Arthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER7 reports
- RESTORIS 160405Mako Surgical Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER7 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.